Literature DB >> 22865805

Angiosarcoma of the liver as a cause of fulminant liver failure.

Marco Montell García1, Raúl Romero Cabello, Raul Romero Feregrino, Mercado Atri Moises, Rafael Trejo Estrada, Padilla-Rodríguez Alvaro, Gama Moreno Manlio Gerardo, Romero Feregrino Rodrigo.   

Abstract

Primary liver sarcomas make up 2% of all malignant neoplasms of the liver; of these, angiosarcoma is the most common type. Primary liver tumours rarely cause fulminant hepatic failure (FHF), which is most frequently caused by non-neoplasmic pathologies. In the case of neoplasms, the most frequent are lymphoma and metastatic carcinomas. We describe the case of a 76-year-old man who suffered from FHF as a result of a liver angiosarcoma and we present a review of the medical literature in which we found only two cases of liver angiosarcomas linked to FHF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865805      PMCID: PMC4543703          DOI: 10.1136/bcr-2012-006417

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

Review 1.  Treatment options for other hepatic malignancies.

Authors:  J G O'Grady
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

2.  Primary non-Hodgkin's lymphomas of the liver with nodular and diffuse infiltration patterns have different prognoses.

Authors:  J F Emile; D Azoulay; J M Gornet; G Lopes; V Delvart; D Samuel; M Reynès; H Bismuth; F Goldwasser
Journal:  Ann Oncol       Date:  2001-07       Impact factor: 32.976

3.  Surgical treatment of adult primary hepatic sarcoma.

Authors:  J L Poggio; D M Nagorney; A G Nascimento; C Rowland; P Kay; R M Young; J H Donohue
Journal:  Br J Surg       Date:  2000-11       Impact factor: 6.939

4.  Fulminant hepatic failure as the initial manifestation of non-Hodgkins lymphoma.

Authors:  P Ghosh; I J Fox; A M Rader; M F Sorrell
Journal:  Am J Gastroenterol       Date:  1995-12       Impact factor: 10.864

5.  Hepatic angiosarcoma. Possible relationship to long-term oral contraceptive ingestion.

Authors:  P S Monroe; R H Riddell; M Siegler; A L Baker
Journal:  JAMA       Date:  1981-07-03       Impact factor: 56.272

6.  Fulminant hepatic failure secondary to neoplastic infiltration of the liver.

Authors:  Pankaj Rajvanshi; Kris V Kowdley; William K Hirota; Jerome B Meyers; Emmet B Keeffe
Journal:  J Clin Gastroenterol       Date:  2005-04       Impact factor: 3.062

Review 7.  ICU management of acute liver failure.

Authors:  Michael L Schilsky; Shyoko Honiden; Lindsay Arnott; Sukru Emre
Journal:  Clin Chest Med       Date:  2009-03       Impact factor: 2.878

Review 8.  Metastatic liver disease and fulminant hepatic failure: presentation of a case and review of the literature.

Authors:  Elias Athanasakis; Eleni Mouloudi; George Prinianakis; Maria Kostaki; Maria Tzardi; Dimitrios Georgopoulos
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-11       Impact factor: 2.566

9.  Fulminant hepatic failure: an unusual presentation of metastatic liver disease.

Authors:  H B Harrison; H M Middleton; J H Crosby; M N Dasher
Journal:  Gastroenterology       Date:  1981-04       Impact factor: 22.682

Review 10.  Acute liver failure as the initial manifestation of hepatic infiltration by a solid tumor: report of 5 cases and review of the literature.

Authors:  Alexandra Alexopoulou; John Koskinas; Melanie Deutsch; Johanna Delladetsima; Demetrios Kountouras; Spyros P Dourakis
Journal:  Tumori       Date:  2006 Jul-Aug
View more
  1 in total

1.  Fulminant hepatic failure secondary to primary hepatic angiosarcoma.

Authors:  Ayokunle T Abegunde; Efe Aisien; Benjamin Mba; Rohini Chennuri; Marin Sekosan
Journal:  Case Rep Gastrointest Med       Date:  2015-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.